Both in human and mouse models of MASLD long-term inflammation and fibrosis were linked to liver-resident IgA producing cells expressing PDL1 (programmed death-ligand 1), hindering body’s capacity to avoid cancer [73]. The gene discussed is CD79A; the disease is metabolic dysfunction-associated steatotic liver disease.